MYCobiome Analysis in Atopic Dermatitis With Head and Neck Involvement (NCT06455891) | Clinical Trial Compass
CompletedNot Applicable
MYCobiome Analysis in Atopic Dermatitis With Head and Neck Involvement
France30 participantsStarted 2024-05-14
Plain-language summary
It is an open study, explorative, proof of concept study concerning mycobiota dysbiosis implication in AD patients with head and neck involvement.
Who can participate
Age range18 Years – 65 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age between 18 and 65 years;
* Male or female;
* The diagnosis of atopic dermatitis (AD) is defined according to the criteria of UK Working Party with at least 3 of the following 5 criteria are present; history of flexural involvement, history of a dry skin, onset under the age of 2, personal history of asthma or allergic rhinitis, history of a pruritic skin condition, and visible flexural dermatitis.
* Generalized AD defined by AD involved ≥50% of total body surface area with head and neck involvement. Or HNAD defined by AD involving at least 80% of the head and neck area with or without AD involvement outside the head and neck area but \<20% of total body surface area.
* With or without topical anti-inflammatory treatments for AD (including; topical steroids and/or topical tacrolimus)
* Free, informed and written consent, signed by the patient and the investigator before any examination required by the trial;
* Affiliation to social security scheme (beneficiary or assignee)
* Healthy control are the same age and sex.
Exclusion Criteria:
* Systemic or local antifungal therapy within 2 months before entry and during the study
* Systemic treatments for AD; including: ciclosporine, dupilumab and others AD biologics, methotrexate, JAK-inhibitors
* Current participation in another interventional research
* Patient with a measure of legal protection
* Psychiatric illness or any other concomitant chronic illness or addiction that could be interfere with the…
What they're measuring
1
Description and comparison of head and neck mycobiome in AD patients, with generalized AD and HNAD, compared to head and neck mycobiome in controls.